Listen to the Episode Below (00:30:20)
335: Garnering Investor Recognition: Josh Blacher, CFO, Therapix Biosciences
Join us when Josh Blacher, CFO of Therapix Biosciences Ltd., shares his career-building journey that spans 10 years inside biotech and 14 years inside the capital markets realm. Josh is the former CFO for Galmed Pharmaceuticals and earlier served as Director of Business Development at Teva Innovative Ventures, an early- and midstage investment and in-licensing arm. He also…